Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Last Updated: January 28, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Faropenem

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Faropenem?

Faropenem is an investigational drug.

There have been 8 clinical trials for Faropenem. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2005.

The most common disease conditions in clinical trials are Tuberculosis, Tuberculosis, Pulmonary, and Pneumonia. The leading clinical trial sponsors are Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd, National University Hospital, Singapore, and Replidyne.

Recent Clinical Trials for Faropenem
Phase 2a Study Early Bactericidal Activity of Rifampin + Meropenem + Amoxicillin/Clavulanate in Adults With Pulmonary TBJohns Hopkins UniversityPhase 2
Early Bactericidal Activity Study of Faropenem(With Amoxicillin/Clavulanic Acid)in Patients With Pulmonary TuberculosisNational University Hospital, SingaporePhase 2
Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Faropenem Plus Amoxicillin/Clavulanic Acid in Healthy VolunteersNational University Hospital, SingaporePhase 1

See all Faropenem clinical trials

Clinical Trial Summary for Faropenem

Top disease conditions for Faropenem
Top clinical trial sponsors for Faropenem

See all Faropenem clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.